Chris Wahl

Chris Wahl currently serves as Senior Vice President and Chief Business Officer at Halozyme, Inc., a position held since July 2023. Previously, Chris held various roles at Biora Therapeutics, advancing from Senior Director of Corporate Development to Corporate Vice President of Strategy and Business Development between June 2015 and July 2023. Prior experience includes co-founding and serving as Chief Operating Officer at Interface, Chief Operating Officer and Director of Business Development at Micropharma Limited, and consulting roles at McKinsey & Company. Early career positions include work in patient health management at Merck and as a research scientist at Shriners Hospital for Children. Chris holds an MD and an MBA from McGill University and a BSc in Accounting and a BA in Biology from Washington and Lee University.